Connect with us

INDUSTRIAL HEMP

Cannabis Science Inc (OTCMKTS:CBIS) Declines Over 3%

Published

on

In the last trading session, the stock price of Cannabis Science Inc (OTCMKTS:CBIS) declined more than 3% to close the day at $0.0482. The decline came at a share volume of 14.54 million compared to average share volume of 17.15 million. After the recent decline, the market cap of firm was noted at $121.5 million.

The buzz

Cash-rich Legal Hemp, Cannabis and Marijuana operations are flattening with aggressive international and domestic expansion programs as licensed producers considerably invest in innovative and latest infrastructure to support expansion initiatives. In a growing market already worth of $130 million in the United States alone as per the Hemp Business journal, key players in the hemp market are focused on continued expansion and growth as progress is recorded in legislature, and in product development while major leaders are educating new customer bases and enhancing products.

A spokesman for Vote Hemp projected there are probably up to 100 hemp CBD brands, and hundreds more processors and growers that focus on yielding hemp-based CBD. Active firms from around the market with prevailing developments include Marijuana Company Of America Inc (OTCMKTS:MCOA), PotNetwork Holdings Inc (OTCMKTS:POTN), Cannabis Science, to name a few,

Cannabis Science, a U.S. entity specializing in the advancement of cannabinoid-based drugs reported recently that its research staff is nearing closure of a novel new cannabinoid drug to treat the Asthma and COPD Overlap Syndrome with clinical studies to begin upon completion.

Their recent development of MDI and Rescue Inhaler drugs for these people in part is the reason this study evolved to cure this under-diagnosed syndrome. While the formulations for these drugs achieve the desired outcomes for the illness targeted as a rescue drug they cannot cure effectively the diagnosis of ACOS. More interesting is the occurrence of ACOS observed among group of people diagnosed with COPD.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of MMJReporter.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure

BRANDS

DETAILS

SCORE

PRODUCT SITES

  • Certified Organic
  • Made In U.S.A
  • Purity Promise
  • Price From $49

9.8

30% OFF Today! “30 0FF”

  • All Natural
  • Made In U.S.A
  • Lab Tested
  • Price From $69

9.7

  • All Natural
  • Made In U.S.A
  • Dissolvable Oral
  • Price From $99

9.6

  • All Natural
  • Made In U.S.A
  • Oral Mist
  • Price From $39

9.5

BRAND
DETAILS
  • All Organic
  • Made In U.S.A
  • Purity Promise
  • Price From $49
SCORE

9.8

PRODUCT SITE
BRAND
DETAILS
  • All Organic
  • Made In U.S.A
  • Lab Tested
  • Price From $69
SCORE

9.7

PRODUCT SITE VIEW PRODUCTS
BRAND
DETAILS
  • All Organic
  • Made In U.S.A
  • Dissolvable Oral
  • Price From $99
SCORE

9.6

PRODUCT SITE VIEW PRODUCTS
BRAND
DETAILS
  • All Organic
  • Made In U.S.A
  • Oral Mist
  • Price From $39
SCORE

9.5

PRODUCT SITE VIEW PRODUCTS
Advertisement
Advertisement

Symbol        Alert        High        Gain

 

  VBIO          $0.67       $4.10      500%

  IMLFF        $0.11       $0.57      400%

  CMXC        $0.25       $0.45      80%

  REPCF       $0.54       $0.79      48%

 

Get Your Latest Winner Delivered to Your Inbox!

FREE

For The Next 48 Hours

Advertisement
Advertisement
Advertisement
Advertisement
Advertisement